Sign in

Maria Fleseriu, MD

@mariafleseriu.bsky.social
888 followers 274 following 21 posts

#EndoSky #MedSky Neuroendocrinologist, Professor, Medicine & Neurosurgery, Director Pituitary Center, Oregon Health &Science University, Portland, Oregon, USA, Board of Directors The Endocrine Soc , Past President Pituitary Soc; Posts not medical advice

PostsRepliesMedia
Maria Fleseriu, MD @mariafleseriu.bsky.social · 22/08/2026
Just out! Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel academic.oup.com/jcem/article...
academic.oup.com
Consensus on biomarker utility for ACTH-dependent Cushing syndrome: a Pituitary Society Modified Delphi Panel
AbstractContext. Biochemical test results are central to clinical decision-making for the diagnosis and management of Cushing syndrome (CS). With emerging
041
Reposted by Maria Fleseriu, MD
pituitarysociety.bsky.social @pituitarysociety.bsky.social · 19/08/2026
Shaping Acromegaly Care: Episode 1, 2 more to come. Join Dr Maria Fleseriu @mariafleseriu.bsky.social @ohsunews.bsky.social & Dr Shlomo Melmed Listen here go.screenpal.com/player/cOjXY... Is intended for US healthcare professionals only #Pituitary #Acromegaly #Endocrinology #MedicalEducation
011
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 23/03/2026
Sporadic #prolactinomas are the most common functioning #pituitary #adenomas, with a female predominance during reproductive years. In men, these adenomas are usually larger and more aggressive www.thelancet.com/journals/lan... #hyperprolactinaemia #MedSky #EndoSky
021
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 30/11/2025
Sporadic #prolactinomas are the most common functioning #pituitary #adenomas, with a female predominance during reproductive years. In men, these adenomas are usually larger and more aggressive www.thelancet.com/journals/lan... #hyperprolactinaemia #prolactin #MedSky #EndoSky #OncSky
061
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 11/11/2025
Read our December Issue, featuring familial hypercholesterolaemia, chronic kidney disease, type 2 diabetes, cyclic Cushing’s syndrome, primary aldosteronism, type 1 diabetes, menopause, obesity, iodine deficiency, & much more tinyurl.com/mwfu4c6m #MedSky #EndoSky #RenalSky #CardioSky
031
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 10/11/2025
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study thelancet.com/journals/lan... cyclic #Cushing's syndrome (#cCS) #MedSky #EndoSky
thelancet.com
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the mo...
133
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 10/10/2025
#Hyperprolactinaemia can result from dopamine antagonist drug effects and reduced prolactin clearance with liver or kidney disease with loss of feedback regulation thelancet.com/journals/lan... #prolactinoma #pituitary #adenoma #MedSky #EndoSky
031
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 19/10/2025
#Prolactinomas are the most common pathological cause of #hyperprolactinaemia and represent approximately half of #pituitary #adenomas thelancet.com/journals/lan... #pituitary #MedSky #EndoSky
001
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 24/10/2025
New—Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study thelancet.com/journals/lan... cyclic #Cushing's syndrome #cCS #MedSky #EndoSky
thelancet.com
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the mo...
111
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 25/10/2025
Even in specialised centres, cyclic #Cushing's syndrome (cCS) diagnosis and management remain challenging with high rates of spontaneous #adrenal #insufficiency, inappropriate surgeries, and poor outcomes www.thelancet.com/journals/lan... cyclic #Cushing's syndrome #cCS #MedSky #EndoSky
thelancet.com
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the mo...
053
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 01/11/2025
Prolactinomas are the most common pathological cause of hyperprolactinaemia and represent approximately half of pituitary adenomas thelancet.com/journals/lan... #prolactinomas #hyperprolactinaemia #pituitary #MedSky #EndoSky
thelancet.com
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management
Hyperprolactinaemia can result from physiological causes, pharmacological agents, or pathological conditions such as prolactin-secreting pituitary adenomas and other pituitary stalk-compressing masses...
001
Reposted by Maria Fleseriu, MD
Nature Reviews Endocrinology @natrevendo.nature.com · 10/10/2025
From our November issue: a Consensus Statement on acromegaly therapeutic outcomes from Andrea Giustina and colleagues go.nature.com/3KJIQa8 #EndoSky #MedSky
A proposed updated algorithm for medical treatment in patients with acromegaly that is inadequately controlled after pituitary surgery.
011
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 20/09/2025
#Hyperprolactinaemia can result from physiological causes, pharmacological agents, or pathological conditions such as prolactin-secreting #pituitary #adenomas and other pituitary stalk-compressing masses www.thelancet.com/journals/lan... #prolactinomas
022
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 09/09/2025
Our October Issue is now online, featuring prediabetes remission, obesity, type 1 diabetes, biased GLP-1 receptor agonists, type 2 diabetes, prolactin-secreting adenomas, malnutrition-related diabetes, food system, NCDs & much more www.thelancet.com/journals/lan... #MedSky #EndoSky #OncSky
114
Reposted by Maria Fleseriu, MD
Adina Turcu @adinaturcu.bsky.social · 28/08/2025
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl #endocrinology @TheEndoSociety
bit.ly
ENDO 2026 Session Submissions
ENDO wouldn’t be possible without the insight and expertise of the Endocrine community. Your ideas are essential to building a dynamic, forward-thinking program that reflects the full breadth of our f...
055
Maria Fleseriu, MD @mariafleseriu.bsky.social · 27/08/2025
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management - The Lancet Diabetes & Endocrinology Personalized Share Link free download authors.elsevier.com/a/1lfru_oLbg...
thelancet.com
Prolactin-secreting adenomas: pathogenesis, diagnosis, and management
Hyperprolactinaemia can result from physiological causes, pharmacological agents, or pathological conditions such as prolactin-secreting pituitary adenomas and other pituitary stalk-compressing masses...
151
Reposted by Maria Fleseriu, MD
Nature Reviews Endocrinology @natrevendo.nature.com · 13/08/2025
In this Review, Daniela Esposito et al discuss the pathophysiology, clinical challenges and management of #diabetes mellitus in patients with #acromegaly (£) bit.ly/3HkGAVp #EndoSky #MedSky
Figure outlining a holistic person-centred approach to management of acromegaly-related diabetes mellitus.
011
Reposted by Maria Fleseriu, MD
Nature Reviews Endocrinology @natrevendo.nature.com · 13/08/2025
New content online: Consensus on acromegaly therapeutic outcomes: an update
nature.com
Consensus on acromegaly therapeutic outcomes: an update
Nature Reviews Endocrinology, Published online: 13 August 2025; doi:10.1038/s41574-025-01148-2In this Consensus Statement, an international group of experts provide updated recommendations on the treatment of acromegaly, including discussion of treatment outcomes.
001
Reposted by Maria Fleseriu, MD
katja-k-vassi.bsky.social @katja-k-vassi.bsky.social · 16/07/2025
#ENDO2025 - enjoyed scientific sessions reconnecting w/ friends and colleagues. A perfect mix of science & fun! @endocrinesociety.bsky.social @lmfendo.bsky.social @garydouglashammer.bsky.social @jeromebertherat.bsky.social @cronchi.bsky.social @mariafleseriu.bsky.social @bferrazdsouza.bsky.social
0125
Reposted by Maria Fleseriu, MD
Frédérique Ruf Zamojski, Ph.D @frederique-nyc.bsky.social · 14/07/2025
Join us for a @endocrinesociety.bsky.social and Pituitary Society session with Dr @mariafleseriu.bsky.social and Dr Ken Ho. I’ll present our new sc multiomics results identifying gene regulatory circuits differentiating NFPA cells and control gonadotropes. @endocrinenews.bsky.social
021
Reposted by Maria Fleseriu, MD
Jérôme Bertherat @jeromebertherat.bsky.social · 11/07/2025
Great & friendly international exchanges on pituitary diseases at the 19th International Pituitary Congress in San Francisco. 👏👏 @mariafleseriu.bsky.social 👏Kristina Isand for presenting the European perspective on #Cushing & venous thrombosis 👍
131
Reposted by Maria Fleseriu, MD
Lauren Fishbein @lmfendo.bsky.social · 10/07/2025
I’m here! #ENDO2025 Board meeting tomorrow and #ECF2025 Friday. One of my favorite events is the early career forum by the @endocrinesociety.bsky.social Can’t wait to meet the trainees and often first timers to ENDO.
083
Reposted by Maria Fleseriu, MD
Frédérique Ruf Zamojski, Ph.D @frederique-nyc.bsky.social · 09/07/2025
SF bound ✈️! Looking forward to meeting colleagues and collaborators and learning about all the science at #ENDO2025 and the Pituitary Society meetings. @endocrinesociety.bsky.social
endocrinesociety.bsky.social
Endocrine Society (@endocrinesociety.bsky.social)
We unite, lead, and grow the global endocrine community to accelerate scientific breakthroughs and improve health worldwide. endocrine.org
083
Maria Fleseriu, MD @mariafleseriu.bsky.social · 24/06/2025
Happy to share our recent #consensus #guideline on how to multidisciplinary manage #pituitary #incidentalomas; good news on data to recommend less frequent #imaging for many microadenomas , but also smaller macroadenomas. @pituitarysociety.bsky.social @ohsubrain.bsky.social @ohsunews.bsky.social
0113
Reposted by Maria Fleseriu, MD
Nature Reviews Endocrinology @natrevendo.nature.com · 24/06/2025
New content online: Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
nature.com
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Nature Reviews Endocrinology, Published online: 24 June 2025; doi:10.1038/s41574-025-01134-8This international Consensus Statement provides guidelines on the management of pituitary incidentalomas.
055
Reposted by Maria Fleseriu, MD
Maria Fleseriu, MD @mariafleseriu.bsky.social · 24/06/2025
So good seeing everyone in our #Cushing family. We are leaving with more work to do, energized by collaborative studies. And let’s not forget Munich charm who is so close to Sibiu. Can’t wait for next one!
042
Maria Fleseriu, MD @mariafleseriu.bsky.social · 24/06/2025
So good seeing everyone in our #Cushing family. We are leaving with more work to do, energized by collaborative studies. And let’s not forget Munich charm who is so close to Sibiu. Can’t wait for next one!
042
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 29/05/2025
New @eclinicalmed.bsky.social: Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey www.thelancet.com/journals/ecl... #PCOS #OpenAccess #MedSky #EndoSky #WomensHealthSky
thelancet.com
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey
Widespread international engagement in 2015 showed major knowledge gaps on broad PCOS features, with follow-up in 2023 showing significant improvement after two international guidelines, widespread di...
032
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 12/05/2025
Mild autonomous cortisol secretion (MACS) associated with #unilateral #adrenal #incidentalomas is responsible for secondary #hypertension that can be safely improved by minimally-invasive #adrenalectomy www.thelancet.com/journals/lan... #MedSky #EndoSky #OncSky #CardioSky
thelancet.com
Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomis...
MACS associated with unilateral adrenal incidentalomas is responsible for secondary hypertension that can be safely improved by minimally-invasive adrenalectomy.
186
Reposted by Maria Fleseriu, MD
Jérôme Bertherat @jeromebertherat.bsky.social · 07/05/2025
The first-ever joint ESPE-ESE congress will begin this Saturday. I look forward to meeting our warm and vibrant community in Copenhagen. 👇👇👇 PS: For those unable to attend, there is still time to register online to participate in this great event !
084
Reposted by Maria Fleseriu, MD
Jérôme Bertherat @jeromebertherat.bsky.social · 24/04/2025
📣TO DAY is WORLD HORMONE DAY 🎆 RT #medsky #Endocrinology #Endosky #BecauseHormonesMatter youtu.be/fwzkw9iEqqA?...
031
Reposted by Maria Fleseriu, MD
Jérôme Bertherat @jeromebertherat.bsky.social · 08/04/2025
Re-post for #Cushing 's awarness day (April 8th)
011
Reposted by Maria Fleseriu, MD
Endocrine News @endocrinenews.bsky.social · 01/04/2025
Honored by both the endocrinesociety.bsky.social and the European Society of Endocrinology with the 2024 Transatlantic Alliance Award fbeuschlein.bsky.social has made significant contributions to endocrine research on both sides of the Atlantic. #EndoSky endocrinenews.endocrine.org/staying-curi...
endocrinenews.endocrine.org
Staying Curious: How Felix Beuschlein, MD, Has Advanced Adrenal Tumor Care Through Transatlantic Collaboration  - Endocrine News
Honored by both the Endocrine Society and the European Society of Endocrinology with the 2024 Transatlantic Alliance Award, Felix Beuschlein, MD, has made significant contributions to endocrine resear...
142
Reposted by Maria Fleseriu, MD
Endocrine Society @endocrinesociety.bsky.social · 25/03/2025
President’s Viewpoint: ENDO 2025 in San Francisco: Vast Opportunities for Attendees to Learn and Network | John Newell-Price, MD, PhD, discusses upcoming opportunities at ENDO 2025: bit.ly/4iQzmW6 #ENDO2025 #endocrinology #EndoSky
bit.ly
ENDO 2025 in San Francisco: Vast Opportunities for Attendees to Learn and Network - Endocrine News
The Endocrine Society offers many things to our thousands of members: continuing education, clinical guidelines, scientific statements, advocacy campaigns, networking groups, career development, award...
041
Maria Fleseriu, MD @mariafleseriu.bsky.social · 25/03/2025
Great review, congrats @fbeuschlein.bsky.social and team! Again the mighty potent #steroids! #Cushing's is associated with increased risk of #cancer & modulating cortisol can bring new avenues for immunotherapy! #EndoSky
073
Reposted by Maria Fleseriu, MD
The Lancet Diabetes & Endocrinology @thelancetendo.bsky.social · 17/03/2025
We spotlight #female #brain health across the lifespan by informing on the role of sex #steroids, particularly #oestradiol, on the female brain & on risk for diseases more prevalent in females, such as #depression & #Alzheimer's disease thelancet.com/journals/lan... #WomensHealth #MedSky #EndoSky
051
Reposted by Maria Fleseriu, MD
Endocrine Society @endocrinesociety.bsky.social · 13/03/2025
Thank you to our members who advocated for the Special Diabetes Program and NIH Funding (bit.ly/4kLTJFC) and made this Hill Day successful: Drs. Ambika Ashraf, Nadia Barghouthi, Ellen Connor, Andrew Dauber, Ilene Fennoy, Abby Fleisch, and @mariafleseriu.bsky.social #FundNIH #FundHealth (1/2)
bit.ly
141
Reposted by Maria Fleseriu, MD
Maria Fleseriu, MD @mariafleseriu.bsky.social · 12/03/2025
Thank you to all, such a productive day discussing research needs and NIH funding in Oregon and beyond ! @merkleysenate.gov And let’s not forget the beautiful #Portland carpet @ohsubrain.bsky.social
0104
Reposted by Maria Fleseriu, MD
Endocrine Society @endocrinesociety.bsky.social · 12/03/2025
We appreciate @wyden.senate.gov and @degette.house.gov for meeting with @jenricher3.bsky.social and @mariafleseriu.bsky.social to discuss the importance of research funding. We encourage everyone to support NIH funding and the Special Diabetes Program by signing our campaign: bit.ly/4kLTJFC
1163
Reposted by Maria Fleseriu, MD
CantlonLab @cantlonlab.bsky.social · 02/03/2025
Some think, ‘I’m from a blue town/state, so writing an article won’t help.’ But it will. Explaining the local impacts of funding cuts gives supporters clear, concrete talking points so they can help advocate for science’s value to health, the economy, and society. It also rallies concern. 🧪🏠
19028
Reposted by Maria Fleseriu, MD
Lauren Fishbein @lmfendo.bsky.social · 28/02/2025
Today is #rarediseaseday. Endocrinology has so many of them. Proud to work in this space. #pheo #para
022
Reposted by Maria Fleseriu, MD
J. Offir, PhD @joffirphd.bsky.social · 24/02/2025
Let's go, let's go, let's go - one month to save telehealth!! Here's a letter campaign, but PLEASE also call your three Members of Congress. They NEED to hear from you about this. actionnetwork.org/letters/medi...
actionnetwork.org
CMS Must Indefinitely Extend Full Telehealth Services
Join us in urging Congress to extend telehealth services indefinitely through the Centers for Medicare and Medicaid Services. Currently, funding for telehealth services through the Medicare program wi...
04426
Reposted by Maria Fleseriu, MD
Richard Ferro, MD MSc @richferro.com · 19/01/2025
If you’re interested in supporting #Medsky, donations would be greatly appreciated! Maintaining the servers/domains/feeds/labels/blocklists/handles for the network takes a lot of time, energy, and money. As the network grows those needs will only increase. Any amount helps to keep the lights on.
venmo.com
Venmo | Richard Ferro
Venmo is a digital wallet that lets you make and share payments with friends. You can easily split the bill, cab fare, or much more. Download the iOS or Android app or sign up on Venmo.com today.
01711
Reposted by Maria Fleseriu, MD
Thanh Neville, MD, MSHS @thanh-neville.bsky.social · 09/01/2025
I am so grateful for the men and women fighting the fires. #LAFires
217124
Reposted by Maria Fleseriu, MD
Amy G Dala, MD @amygdalamd.bsky.social · 06/01/2025
Not saying my break was perfect, just sayin’ it was long enough for me to forget my Epic password 🥹
3341
Reposted by Maria Fleseriu, MD
Endocrine Society @endocrinesociety.bsky.social · 02/01/2025
Welcome! We provide educational, leadership and advocacy opportunities for endocrinologists, researchers, and healthcare practitioners. To access the latest articles from our publications or to learn more about submitting your research, follow @endosocjournals.bsky.social. #endocrinology #EndoSky
0103
Reposted by Maria Fleseriu, MD
Endocrine Society Journals @endosocjournals.bsky.social · 02/01/2025
Papillary #craniopharyngioma: an integrated and comprehensive Featured review covering surgical and medical therapies in #EndocrineReviews #FreeToView #RareDiseases @endocrinesociety.bsky.social doi.org/10.1210/endr...
doi.org
Papillary Craniopharyngioma: An Integrative and Comprehensive Review
Abstract. Papillary craniopharyngioma (PCP) is a rare type of tumor, comprising ∼20% of all craniopharyngioma (CP) cases. It is now recognized as a separat
022